PHILADELPHIA & HONG KONG--(BUSINESS WIRE)--Biofield Corp. (OTCBB:BZEC), today announced that it has shipped the initial order of its proprietary Biofield Diagnostic System for the early detection of breast cancer units (the “BDS”), to an exclusive distributor representing the Mexican, Central and Latin American markets. The distributor, MacKay Health Systems, (“MHS”), a company primarily made up of nationals from the licensed territories, acquired the rights to Mexico and various Central & Latin American countries via an exclusive distribution agreement it entered into with MacKay Innotech LTD, (“MHK”), a Hong Kong company. MKH holds a worldwide master license from Biofield to manufacture and distribute the BDS units.
